# Ashermed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ashermed

- Industry: Healthcare IT
- Headquarters: Shanghai, China
- Website: www.ashermed.com
- Total disclosed funding: $15M
- Latest round: Series B (May 11, 2022)
- Investors on record: 5

## About

Established in 2013 and based in Shanghai, China, Ashermed is a contract research organization that provides clinical research and related technical services for innovation medical and instrument enterprises. The company built cooperative relations with Johnson & Johnson, Gilead Sciences, Jiangsu Hengrui Medicine, and other enterprises.

The company mainly provides clinical research technology platforms, such as intelligent clinical program design platform, intelligent clinical data collection, monitoring platform, and intelligent clinical management platform. These platforms use Internet technology to effectively reduce the cost of medical research and provide research efficiency. Besides the clinical research technology platforms, the company also operates a chronic disease management platform that provides disease analysis, data queries, and other services for patients.

The company's revenue is generated by providing clinical research services for medical and instrument enterprises. In the past 3 years, its clinical research services have developed rapidly at a compound annual growth rate of 150%.

## Funding rounds

- Series B, May 11, 2022, $15M — Qiming Venture Partners, Score Capital, Insight Capital, Shanghai Daohe Long-term Investment Management
- Series A, Mar 29, 2021 — Topping Capital, Insight Capital

## Investors

- Topping Capital (https://capitalatlas.ai/funds/topping-capital) — Series A
- Insight Capital — Series A, Series B
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series B
- Score Capital (https://capitalatlas.ai/funds/score-capital) — Series B
- Shanghai Daohe Long-term Investment Management — Series B